CCC
SNY icon

Crescent Capital Consulting’s Sanofi SNY Stock Holding History

Crescent Capital Consulting’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$144K Hold
2,886
– – 0.02% 202
2021
Q3 		$140K Hold
2,886
– – 0.03% 209
2021
Q2 		$151K Hold
2,886
– – 0.03% 195
2021
Q1 		$144K Hold
2,886
– – 0.03% 202
2020
Q4 		$140K Buy
+2,886
New +$142K 0.04% 182

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Crescent Capital Consulting's SNY Position: Q4 2021 in Review

Crescent Capital Consulting held its Sanofi (SNY) position steady in Q4 2021 at 2,886 shares worth $144K. The position accounts for 0.02% of the portfolio, ranked #202.

Crescent Capital Consulting first reported a position in SNY in Q4 2020 and has held it in 5 quarters since. The position peaked at $151K in Q2 2021. 624 funds tracked by Wall St. Rank hold SNY as of Q4 2021.

  • Crescent Capital Consulting held 2,886 shares of Sanofi worth $144K as of Q4 2021.
  • Crescent Capital Consulting left its Sanofi share count unchanged in Q4 2021.
  • Sanofi made up 0.02% of Crescent Capital Consulting's portfolio in Q4 2021, its #202 holding.
  • Crescent Capital Consulting first reported a position in Sanofi in Q4 2020 and has held it in 5 quarters since.
  • Crescent Capital Consulting's Sanofi position peaked at $151K in Q2 2021.
  • 624 funds tracked by Wall St. Rank held Sanofi as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.